Clark Timothy W I, Cohen Raphael A, Kwak Andrew, Markmann James F, Stavropoulos S William, Patel Aalpen A, Soulen Michael C, Mondschein Jeffrey I, Kobrin Sidney, Shlansky-Goldberg Richard D, Trerotola Scott O
Department of Radiology, Division of Interventional Radiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
Radiology. 2007 Jan;242(1):286-92. doi: 10.1148/radiol.2421051718. Epub 2006 Nov 7.
To retrospectively review outcomes following angioplasty of nonmaturing autogenous hemodialysis fistulas.
Institutional review board exemption was received for this HIPAA-compliant retrospective study; informed consent was waived. During 48 months, 101 patients underwent fistulography for percutaneous salvage of nonmaturing native fistulas. Clinical and technical success, need for secondary interventions, and complications were recorded according to consensus definitions. Patency following angioplasty was estimated with the Kaplan-Meier technique. Patient age, sex, ethnicity, fistula age, fistula type, number of stenoses, maximal angioplastic balloon diameter used, and presence of palpable thrill following angioplasty were examined as predictors of primary patency of the fistula following intervention by using Cox proportional hazards model.
Mean patient age was 58 years; 35% were women. Median time from fistula creation to fistulography was 2.5 months. Hemodynamically significant (>50%) stenoses were identified in 88% (89 of 101) of patients; angioplasty was attempted in 96% (85 of 89). Technical success was achieved in 92% (78 of 85) of fistulas following angioplasty; clinical success of normal hemodialysis with total access blood flow of more than 500 mL/min occurred following 88% (75 of 85) of angioplastic interventions. No major and two minor complications occurred. Mean primary unassisted patency at 3, 6, and 12 months was 60%+/-6% (95% confidence interval), 45%+/-6%, and 34%+/-6%, respectively. Additional angioplasty (n=12), stent placement (n=1), or thrombectomy (n=1) during subsequent interventions resulted in mean secondary patency at 3, 6, and 12 months of 82%+/-4%, 79%+/-5%, and 75%+/-6%, respectively. Patients without thrill following angioplasty were more than twice as likely to lose patency as patients with thrill (P=.035). No relationship was seen between primary patency and other predictors examined.
Early fistulography enables identification of underlying areas of stenosis in nonmaturing fistulas, which can be safely and effectively treated with angioplasty. With continued surveillance and repeat interventions, functional patency can be sustained in the majority of fistulas.
回顾性分析未成熟自体血液透析内瘘血管成形术后的结果。
本符合健康保险流通与责任法案(HIPAA)的回顾性研究获得机构审查委员会豁免;无需知情同意。在48个月期间,101例患者接受了用于经皮挽救未成熟自体动静脉内瘘的瘘管造影。根据共识定义记录临床和技术成功率、二次干预需求及并发症。血管成形术后的通畅率采用Kaplan-Meier技术进行评估。通过Cox比例风险模型,将患者年龄、性别、种族、内瘘使用时间、内瘘类型、狭窄数量、血管成形术中使用的最大球囊直径以及血管成形术后有无可触及的震颤作为干预后内瘘初次通畅的预测因素进行分析。
患者平均年龄为58岁;35%为女性。从内瘘建立到瘘管造影的中位时间为2.5个月。88%(101例中的89例)的患者存在血流动力学意义重大(>50%)的狭窄;其中96%(89例中的85例)尝试进行血管成形术。血管成形术后92%(85例中的78例)的内瘘获得技术成功;88%(85例中的75例)的血管成形术干预后实现了正常血液透析,总血流量超过500 mL/min的临床成功。未发生重大并发症,发生了2例轻微并发症。3个月、6个月和12个月时的初次无辅助通畅率分别为60%±6%(95%置信区间)、45%±6%和34%±6%。后续干预期间进行的额外血管成形术(n = 12)、支架置入术(n = 1)或血栓切除术(n = 1)使3个月、6个月和12个月时的二次通畅率分别为82%±4%、79%±5%和75%±6%。血管成形术后无震颤的患者失去通畅的可能性是有震颤患者的两倍多(P = 0.035)。未发现初次通畅与所检查的其他预测因素之间存在关联。
早期瘘管造影能够识别未成熟内瘘潜在的狭窄区域,血管成形术可安全有效地治疗这些狭窄。通过持续监测和重复干预,大多数内瘘能够维持功能通畅。